SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Alkem launches Neuceno (cenobamate) for adult partial-onset seizures

Alkem Laboratories Ltd said it has launched Neuceno (cenobamate) for the treatment of partial-onset seizures in adult patients.

ALKEM

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.